Robert A Jr McCabe

NHI director McCabe buys 890 shares at $71.65; 100% of prior buys well-timed at 90-day mark.

Robert A Jr McCabe, a director of National Health Investors Inc, purchased 890 shares at $71.65 on 2026-06-15, increasing his holdings from 43.3K to 44.2K shares (+2.1%). The stock is currently trading at $70.70, down -22.6% from its 52-week high of $91.38 and down -5.3% over the past 30 days. Across his cross-ticker track record, McCabe has executed 1 prior open-market buy with a 90-day win rate of 100.00%, and his singular prior purchase at NHI on 2024-05-31 posted a +22.2% 90-day return. The company's fundamentals show revenue growth of +12.1% annually and a P/E of 23.10, with latest-quarter revenue of $115.1M and net income of $40.1M. McCabe's historical buy timing at this specific ticker is perfect, though recent price momentum has been negative over both 30 and 90 days.

PNFP Chairman McCabe sold 50,589 shares at $105.29; holdings drop to 209,280 shares

Robert McCabe Jr., PNFP's Chairman, sold 50,589 shares on 2025-05-07 at $105.29, reducing his holdings by 19.5% from 259,869 to 209,280 shares. His prior trades at PNFP show a 100% well-timed pattern at the 90-day mark (2 of 2 sells fell 14.4% and 14.9% after the transaction), suggesting potential foreknowledge of or sensitivity to downside risk. However, the current price of $105.55 is -18.7% from the 52-week high, and the stock has declined 14.7% over 90 days, which may reflect deteriorating fundamentals or broader headwinds rather than a timing signal from this specific sale. McCabe's cross-ticker sell track record shows 42.86% well-timed outcomes over 10 prior sales, a performance marginally better than a random coin flip, and his recent 30-day return on the open market has averaged -3.0%, offering limited predictive power for this transaction.

PNFP Chairman Robert A McCabe Jr sells 40,000 shares (18.2% of holdings) for $4.6M on 2025-02-24

McCabe executed 3 separate sales totaling 40,000 shares for $4,552,208.09 at an average price of $113.81, reducing his holdings from 219.3K to 179.3K shares. The stock has declined 8.9% over the past 30 days and 10.9% over 90 days, trading 12.7% below its 52-week high of $129.87. His cross-ticker sell history shows a 20.00% well-timed rate (only 1 of 7 prior sells preceded subsequent declines), while at PNFP specifically, 1 of 3 prior measurable sells was well-timed at the 90-day mark. The sale occurs against a backdrop of recent weakness in the stock, though the insider's track record does not demonstrate consistent predictive accuracy on either a cross-ticker or single-ticker basis.

PNFP Chairman MCCABE ROBERT A JR sells 50,000 shares for $6,204,281.50; holds 123,000 shares post-sale.

Robert A McCabe Jr., Chairman of Pinnacle Financial Partners, executed 2 separate open-market sales on 2024-12-06 totaling 50,000 shares for $6,204,281.50 at blended average price $124.09, reducing his holdings by 28.9% from 173,000 to 123,000 shares. The sell prices ($123.97 and $124.59) were near the 52-week high of $129.87, and notably the current price has declined to $120.91, down 0.1% over 30 days but up 33.5% over 90 days. McCabe's cross-ticker track record shows 5 prior sells with an average 90-day return of +5.2% and a 20% well-timed rate; his same-ticker history at PNFP includes 5 prior sales, with only 1 of 5 proving well-timed at the 90-day mark, suggesting inconsistent sell-timing pattern at this ticker. The transaction represents a substantial reduction in insider position size near elevated valuations (P/E 22.31, market cap $9.3B).